| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heteroptera | 5 | 2024 | 13 | 3.270 |
Why?
|
| Nanoparticles | 10 | 2024 | 235 | 3.060 |
Why?
|
| Mammary Glands, Animal | 10 | 2025 | 482 | 2.260 |
Why?
|
| Mammary Neoplasms, Experimental | 6 | 2025 | 247 | 2.070 |
Why?
|
| Breast Neoplasms | 13 | 2025 | 2506 | 1.400 |
Why?
|
| Metal Nanoparticles | 4 | 2024 | 42 | 1.310 |
Why?
|
| Phylogeny | 5 | 2024 | 694 | 1.300 |
Why?
|
| Neoplasms | 6 | 2024 | 2785 | 1.300 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 547 | 1.140 |
Why?
|
| Phylogeography | 2 | 2024 | 16 | 1.140 |
Why?
|
| Animals | 49 | 2025 | 34154 | 1.110 |
Why?
|
| Climate Change | 2 | 2024 | 41 | 1.090 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4355 | 0.980 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2020 | 3575 | 0.960 |
Why?
|
| Mice | 36 | 2025 | 17733 | 0.950 |
Why?
|
| Gold | 1 | 2024 | 49 | 0.930 |
Why?
|
| Energy Transfer | 2 | 2024 | 16 | 0.910 |
Why?
|
| Optogenetics | 1 | 2024 | 69 | 0.910 |
Why?
|
| Biodiversity | 1 | 2024 | 64 | 0.900 |
Why?
|
| Nanostructures | 3 | 2020 | 52 | 0.890 |
Why?
|
| Zinc | 1 | 2024 | 127 | 0.890 |
Why?
|
| Epithelial Cells | 8 | 2024 | 912 | 0.880 |
Why?
|
| Genetic Vectors | 4 | 2020 | 940 | 0.870 |
Why?
|
| Dopaminergic Neurons | 1 | 2024 | 48 | 0.870 |
Why?
|
| Hemiptera | 1 | 2023 | 10 | 0.860 |
Why?
|
| Cerium | 2 | 2024 | 2 | 0.860 |
Why?
|
| Cranial Irradiation | 1 | 2024 | 69 | 0.860 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 139 | 0.820 |
Why?
|
| Stem Cells | 4 | 2021 | 701 | 0.810 |
Why?
|
| Carcinogenesis | 6 | 2021 | 334 | 0.800 |
Why?
|
| Wound Infection | 1 | 2022 | 53 | 0.800 |
Why?
|
| Gadolinium | 3 | 2020 | 104 | 0.790 |
Why?
|
| Precancerous Conditions | 3 | 2023 | 283 | 0.790 |
Why?
|
| Genome, Mitochondrial | 1 | 2022 | 31 | 0.770 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 620 | 0.730 |
Why?
|
| Gene Editing | 1 | 2023 | 194 | 0.720 |
Why?
|
| Chlorine | 1 | 2020 | 14 | 0.710 |
Why?
|
| Free Radicals | 1 | 2020 | 31 | 0.710 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 34 | 0.700 |
Why?
|
| Thermography | 1 | 2020 | 11 | 0.690 |
Why?
|
| Glutathione | 3 | 2023 | 192 | 0.690 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 196 | 0.670 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2019 | 5 | 0.650 |
Why?
|
| Oncogenes | 4 | 2024 | 169 | 0.650 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 106 | 0.640 |
Why?
|
| Lentivirus | 5 | 2020 | 83 | 0.630 |
Why?
|
| Transfection | 2 | 2020 | 1069 | 0.630 |
Why?
|
| Antineoplastic Agents | 6 | 2020 | 1663 | 0.610 |
Why?
|
| Insecta | 2 | 2022 | 57 | 0.600 |
Why?
|
| Oxygen | 2 | 2018 | 555 | 0.590 |
Why?
|
| DNA Helicases | 1 | 2019 | 226 | 0.580 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 311 | 0.560 |
Why?
|
| Receptor, ErbB-2 | 5 | 2016 | 514 | 0.550 |
Why?
|
| Keratin-6 | 4 | 2016 | 13 | 0.540 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 211 | 0.540 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1272 | 0.540 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 1899 | 0.500 |
Why?
|
| Skin Neoplasms | 2 | 2020 | 803 | 0.490 |
Why?
|
| RNA, Ribosomal | 2 | 2012 | 63 | 0.480 |
Why?
|
| Gene Transfer Techniques | 2 | 2023 | 357 | 0.470 |
Why?
|
| Neurons | 1 | 2024 | 1966 | 0.460 |
Why?
|
| China | 3 | 2024 | 245 | 0.460 |
Why?
|
| RNA, Ribosomal, 28S | 1 | 2013 | 4 | 0.420 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 2409 | 0.420 |
Why?
|
| DNA, Mitochondrial | 2 | 2024 | 210 | 0.410 |
Why?
|
| Wnt Proteins | 1 | 2013 | 195 | 0.410 |
Why?
|
| Rats | 3 | 2025 | 3685 | 0.400 |
Why?
|
| Archaea | 1 | 2012 | 10 | 0.390 |
Why?
|
| Melanoma | 1 | 2019 | 832 | 0.390 |
Why?
|
| Eukaryota | 1 | 2012 | 21 | 0.390 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1600 | 0.390 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 262 | 0.370 |
Why?
|
| Cell Nucleus | 2 | 2024 | 677 | 0.370 |
Why?
|
| Ribosomes | 1 | 2012 | 138 | 0.370 |
Why?
|
| Action Potentials | 2 | 2024 | 500 | 0.370 |
Why?
|
| Bayes Theorem | 3 | 2022 | 282 | 0.360 |
Why?
|
| Cell Line, Tumor | 13 | 2023 | 3342 | 0.350 |
Why?
|
| Neoplasms, Experimental | 1 | 2011 | 213 | 0.340 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 101 | 0.340 |
Why?
|
| Retroviridae | 3 | 2023 | 196 | 0.340 |
Why?
|
| Silicon Dioxide | 3 | 2020 | 27 | 0.320 |
Why?
|
| Transcription Factors | 1 | 2019 | 2608 | 0.320 |
Why?
|
| Female | 30 | 2025 | 66318 | 0.310 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2019 | 217 | 0.260 |
Why?
|
| Cell Plasticity | 2 | 2017 | 32 | 0.260 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 134 | 0.250 |
Why?
|
| beta Catenin | 3 | 2023 | 206 | 0.250 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 223 | 0.240 |
Why?
|
| Genes, Reporter | 4 | 2020 | 383 | 0.240 |
Why?
|
| Porphyrins | 1 | 2024 | 16 | 0.240 |
Why?
|
| Humans | 30 | 2025 | 124488 | 0.240 |
Why?
|
| Electrodes | 1 | 2024 | 99 | 0.230 |
Why?
|
| Keratoderma, Palmoplantar | 1 | 2024 | 4 | 0.230 |
Why?
|
| Animal Distribution | 1 | 2024 | 10 | 0.230 |
Why?
|
| Cell Proliferation | 8 | 2020 | 2304 | 0.230 |
Why?
|
| Serpins | 1 | 2024 | 27 | 0.230 |
Why?
|
| Epidermis | 1 | 2024 | 60 | 0.230 |
Why?
|
| Benzopyrans | 1 | 2024 | 19 | 0.220 |
Why?
|
| Motor Cortex | 1 | 2024 | 76 | 0.220 |
Why?
|
| Diffusion | 1 | 2024 | 59 | 0.220 |
Why?
|
| Light | 1 | 2024 | 177 | 0.220 |
Why?
|
| Cell Survival | 4 | 2020 | 805 | 0.220 |
Why?
|
| Cysteine Endopeptidases | 1 | 2024 | 114 | 0.220 |
Why?
|
| Hydrogen Peroxide | 3 | 2023 | 113 | 0.210 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 19 | 0.210 |
Why?
|
| Boron | 1 | 2022 | 3 | 0.210 |
Why?
|
| Peptidoglycan | 1 | 2022 | 16 | 0.210 |
Why?
|
| Biological Evolution | 1 | 2024 | 224 | 0.210 |
Why?
|
| Surface Properties | 2 | 2020 | 83 | 0.210 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 93 | 0.210 |
Why?
|
| Boron Compounds | 1 | 2022 | 32 | 0.210 |
Why?
|
| Particle Size | 2 | 2020 | 121 | 0.200 |
Why?
|
| India | 1 | 2023 | 220 | 0.200 |
Why?
|
| Proteogenomics | 1 | 2023 | 67 | 0.200 |
Why?
|
| CD40 Ligand | 1 | 2022 | 64 | 0.200 |
Why?
|
| Neoptera | 1 | 2022 | 1 | 0.200 |
Why?
|
| Thiazoles | 1 | 2023 | 97 | 0.200 |
Why?
|
| Microbubbles | 1 | 2022 | 7 | 0.200 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 97 | 0.200 |
Why?
|
| Acoustics | 1 | 2022 | 20 | 0.200 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 246 | 0.200 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 300 | 0.190 |
Why?
|
| Drug Carriers | 2 | 2023 | 100 | 0.190 |
Why?
|
| Nucleic Acid Conformation | 2 | 2013 | 184 | 0.190 |
Why?
|
| Electric Impedance | 1 | 2022 | 57 | 0.190 |
Why?
|
| Temperature | 2 | 2020 | 304 | 0.190 |
Why?
|
| Metformin | 1 | 2023 | 148 | 0.190 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 294 | 0.180 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 15 | 0.180 |
Why?
|
| Infrared Rays | 1 | 2020 | 24 | 0.180 |
Why?
|
| Silver | 1 | 2020 | 22 | 0.180 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 24 | 0.180 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2020 | 11 | 0.180 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 30 | 0.170 |
Why?
|
| Neuroprotection | 1 | 2020 | 26 | 0.170 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 794 | 0.170 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 11 | 0.170 |
Why?
|
| STAT5 Transcription Factor | 2 | 2018 | 90 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 606 | 0.170 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2414 | 0.170 |
Why?
|
| Hyperthermia, Induced | 2 | 2018 | 47 | 0.170 |
Why?
|
| HEK293 Cells | 2 | 2020 | 753 | 0.170 |
Why?
|
| Adenoviridae | 1 | 2023 | 604 | 0.170 |
Why?
|
| Spine | 1 | 2020 | 143 | 0.170 |
Why?
|
| Bismuth | 1 | 2020 | 79 | 0.170 |
Why?
|
| Plasmids | 1 | 2020 | 513 | 0.160 |
Why?
|
| Theranostic Nanomedicine | 2 | 2017 | 5 | 0.160 |
Why?
|
| Models, Genetic | 2 | 2013 | 759 | 0.160 |
Why?
|
| Sepsis | 1 | 2024 | 479 | 0.160 |
Why?
|
| Computational Biology | 3 | 2014 | 820 | 0.160 |
Why?
|
| Mitochondria | 1 | 2024 | 690 | 0.160 |
Why?
|
| A549 Cells | 1 | 2018 | 43 | 0.160 |
Why?
|
| Wound Healing | 1 | 2022 | 458 | 0.160 |
Why?
|
| Inflammation | 2 | 2024 | 1417 | 0.160 |
Why?
|
| Bacteria | 1 | 2022 | 483 | 0.160 |
Why?
|
| Spleen | 1 | 2019 | 280 | 0.150 |
Why?
|
| Juglandaceae | 1 | 2018 | 1 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 188 | 0.150 |
Why?
|
| Copper | 1 | 2018 | 63 | 0.150 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 71 | 0.150 |
Why?
|
| Cell Movement | 2 | 2019 | 835 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 290 | 0.150 |
Why?
|
| Histones | 1 | 2022 | 534 | 0.150 |
Why?
|
| Diptera | 1 | 2018 | 22 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 443 | 0.150 |
Why?
|
| Cysteine | 1 | 2018 | 135 | 0.150 |
Why?
|
| Magnetic Fields | 1 | 2018 | 6 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 1761 | 0.150 |
Why?
|
| Cell Differentiation | 3 | 2024 | 1930 | 0.150 |
Why?
|
| Base Sequence | 2 | 2013 | 3097 | 0.140 |
Why?
|
| Naphthoquinones | 1 | 2017 | 5 | 0.140 |
Why?
|
| Electrochemical Techniques | 1 | 2017 | 6 | 0.140 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 36 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 2057 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2024 | 1491 | 0.140 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 53 | 0.140 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3875 | 0.140 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 52 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 550 | 0.140 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 101 | 0.130 |
Why?
|
| Iron Compounds | 1 | 2016 | 2 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 1005 | 0.130 |
Why?
|
| X-Rays | 1 | 2015 | 27 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 566 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2614 | 0.120 |
Why?
|
| Apoptosis | 6 | 2021 | 1787 | 0.120 |
Why?
|
| Oxidative Stress | 1 | 2020 | 803 | 0.120 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 656 | 0.120 |
Why?
|
| Signal Transduction | 6 | 2020 | 4535 | 0.120 |
Why?
|
| Claudins | 1 | 2014 | 29 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 80 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 572 | 0.120 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 144 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3052 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2018 | 711 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 209 | 0.110 |
Why?
|
| Tungsten Compounds | 1 | 2013 | 3 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.110 |
Why?
|
| Ischemia | 1 | 2017 | 355 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 103 | 0.110 |
Why?
|
| Phototherapy | 1 | 2013 | 34 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 42 | 0.110 |
Why?
|
| Iron | 1 | 2016 | 268 | 0.110 |
Why?
|
| Gene Amplification | 1 | 2014 | 228 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2024 | 1626 | 0.100 |
Why?
|
| DNA, Ribosomal | 1 | 2013 | 54 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2013 | 49 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 12 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 429 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 221 | 0.100 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 67 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2013 | 61 | 0.100 |
Why?
|
| Liver | 1 | 2019 | 1761 | 0.100 |
Why?
|
| Nitric Oxide | 1 | 2015 | 445 | 0.100 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2012 | 18 | 0.100 |
Why?
|
| Peptidyl Transferases | 1 | 2012 | 6 | 0.100 |
Why?
|
| Contig Mapping | 1 | 2012 | 55 | 0.100 |
Why?
|
| Conserved Sequence | 1 | 2013 | 293 | 0.100 |
Why?
|
| Likelihood Functions | 1 | 2012 | 111 | 0.100 |
Why?
|
| Cisplatin | 1 | 2013 | 238 | 0.100 |
Why?
|
| Base Pairing | 1 | 2012 | 43 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 95 | 0.100 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 14 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2013 | 625 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 284 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 234 | 0.090 |
Why?
|
| Oxidation-Reduction | 2 | 2023 | 442 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2012 | 459 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 720 | 0.080 |
Why?
|
| Chromatin | 2 | 2023 | 554 | 0.080 |
Why?
|
| I-kappa B Kinase | 2 | 2024 | 61 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 334 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 1296 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2012 | 426 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2024 | 3753 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 721 | 0.080 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 374 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 673 | 0.080 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 87 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1318 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1024 | 0.070 |
Why?
|
| Software | 1 | 2012 | 686 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 998 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 468 | 0.070 |
Why?
|
| DNA Damage | 1 | 2010 | 516 | 0.070 |
Why?
|
| Keratins | 1 | 2006 | 55 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2012 | 984 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2017 | 426 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 646 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 570 | 0.060 |
Why?
|
| Brain | 1 | 2017 | 3002 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1529 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2018 | 297 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 887 | 0.060 |
Why?
|
| Polyphenols | 1 | 2023 | 19 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 24 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 1243 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 98 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 38 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 392 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 73 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 209 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2013 | 174 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6285 | 0.050 |
Why?
|
| Male | 4 | 2021 | 61052 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 173 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 151 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 488 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2023 | 491 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 355 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 46 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 81 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 203 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 26514 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 2018 | 9 | 0.040 |
Why?
|
| Carya | 1 | 2018 | 1 | 0.040 |
Why?
|
| Adult | 1 | 2019 | 29397 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 6 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 23 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 285 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 107 | 0.040 |
Why?
|
| Ferric Compounds | 1 | 2018 | 37 | 0.040 |
Why?
|
| Luminescent Agents | 1 | 2017 | 7 | 0.040 |
Why?
|
| Risperidone | 1 | 2018 | 60 | 0.040 |
Why?
|
| Osteocytes | 1 | 2017 | 15 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 459 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 675 | 0.030 |
Why?
|
| Intestines | 1 | 2021 | 572 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 111 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1342 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2017 | 66 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 215 | 0.030 |
Why?
|
| Glass | 1 | 2016 | 12 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 186 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2015 | 47 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 222 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 599 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 98 | 0.030 |
Why?
|
| Virus Latency | 1 | 2015 | 61 | 0.030 |
Why?
|
| Fluorescence | 1 | 2014 | 94 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 58 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 373 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 16 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 148 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 95 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1242 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 23 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 38 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2040 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 68 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1004 | 0.030 |
Why?
|
| Materials Testing | 1 | 2013 | 73 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 177 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 117 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 128 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 13 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 348 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 14 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 2 | 0.030 |
Why?
|
| Colloids | 1 | 2013 | 17 | 0.030 |
Why?
|
| Porosity | 1 | 2013 | 38 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 290 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2012 | 10 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 75 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 17 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 350 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 25 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 354 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 54 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6084 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 122 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4426 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 317 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2013 | 207 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 147 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 147 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 764 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 809 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1687 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 173 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 266 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 258 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 625 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 681 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 504 | 0.020 |
Why?
|
| Mutation | 2 | 2016 | 5805 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 862 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 95 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2014 | 890 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1459 | 0.020 |
Why?
|
| Keratin-9 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Alpharetrovirus | 1 | 2008 | 5 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2010 | 162 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2773 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 93 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 106 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 885 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2868 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 180 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2089 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 275 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 10182 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 4572 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 1001 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1696 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 12316 | 0.010 |
Why?
|